Lyle McDonald digs into the claim that Lilly's experimental drug burns more energy, and says the answer won't please everyone.
Recap by typeshit. Full story at Lyle McDonald.
Trials show large weight loss on semaglutide, and medical attention is shifting to the health effects that come with it.
Doctors at the Kenya launch of Ozempic and Wegovy cited SELECT and FLOW trial results, while warning that long-term liver evidence is still unsettled.
A new Journal of the American Chemical Society study describes a solid-state method for finding and quantifying peptide biomarkers in diluted human serum.
21:14
A rapid-fire explainer from Dr. Ashley Froese covering 50 different peptides. Her claims are her own, not established medical guidance.
The longevity researcher argues the FDA system has grown too slow and costly, saying it favors big drugmakers. He offers this as the reason reform efforts emerged.
A short post on how the two semaglutide shots differ: Ozempic is used for A1C, Wegovy for weight and metabolic health. It is a basic overview.
Loading…